By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche Diagnostics has terminated a sales and distribution deal with Response Biomedical after the Canadian diagnostic test maker failed to get US regulatory clearance of its cardiovascular tests on its most current platform, Response Bio announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.